vorinostat has been researched along with Neurodevelopmental Disorders in 1 studies
Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).
Neurodevelopmental Disorders: These are a group of conditions with onset in the developmental period. The disorders typically manifest early in development, often before the child enters grade school, and are characterized by developmental deficits that produce impairments of personal, social, academic, or occupational functioning. (From DSM-5).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Poeta, L | 1 |
| Padula, A | 1 |
| Attianese, B | 1 |
| Valentino, M | 1 |
| Verrillo, L | 1 |
| Filosa, S | 1 |
| Shoubridge, C | 1 |
| Barra, A | 1 |
| Schwartz, CE | 1 |
| Christensen, J | 1 |
| van Bokhoven, H | 1 |
| Helin, K | 1 |
| Lioi, MB | 1 |
| Collombat, P | 1 |
| Gecz, J | 1 |
| Altucci, L | 1 |
| Di Schiavi, E | 1 |
| Miano, MG | 1 |
1 other study available for vorinostat and Neurodevelopmental Disorders
| Article | Year |
|---|---|
Histone demethylase KDM5C is a SAHA-sensitive central hub at the crossroads of transcriptional axes involved in multiple neurodevelopmental disorders.
Topics: Animals; Caenorhabditis elegans; Cell Line; DNA-Binding Proteins; Female; HEK293 Cells; Histone Deac | 2019 |